Search
healthcare › ... › peripheral-artery-disease
… blood supply to the extremities. These techniques work best when the diseased portion of the artery is relatively …
contact-us
… Call 713-798-8737 IT and Zoom videoconferencing: Visit the IT Portal (Baylor login required) or call … and services are correctly represented to our end users. Visit our Supplier Diversity site for more information. …
research › ... › resources
… Hosts private lab track hub for UCSC, WashU, Ensembl browsers Accessed via SMB, AFP, or NFS …
healthcare › clinical-trials › h-42584
… of niraparib, an orally available small molecule PARP inhibitor when administered concurrently with definitive regional radiotherapy for treatment of cervical cancer. … Study of niraparib with radiotherapy for treatment of metastatic invasive carcinoma of the cervix …
healthcare › clinical-trials › h-49648
… GEKO as an adjunct for the treatment of lower extremity edema in acute heart …
healthcare › clinical-trials › h-46767
… and evaluate genomic biomarkers found in menstrual fluid for the development of a non-invasive diagnostic test for uterine disorders such as endometriosis and adenomyosis, … staging and classification of disease. A non-invasive test for uterine disorders would fundamentally change how these …
news › tumor-induced-b-cell-changes-reveal-potential-biomarker-for-treatment-response-in-triple-negative-breast-cancer
… have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast … the crosstalk between the tumor and the body. Many systemic changes arise because of how the body responds to the … Tumor-induced B cell changes reveal potential biomarker for treatment response in …
news › dr-mary-dickinson-named-a-2023-fellow-by-the-american-association-for-the-advancement-of-science
… has been named a 2023 Fellow by the American Association for the Advancement of Science . This honor comes as AAAS celebrates its 150th anniversary of the … has held many leadership positions, including academic director of the Optical Imaging and Vital Microscopy Core, …
healthcare › clinical-trials › h-56035
… This phase II/III trial compares the addition of nivolumab to the usual treatment of … treat patients with advanced stomach or esophageal cancer. For more information: https://clinicaltrials.gov/study/NCT06203600 … PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer …
research › ... › advocacy
… for Texas’ s 7th congressional district, John Culberson, visits Baylor College of Medicine. Culberson met with … U.S. Representative Visits Baylor College of Medicine …